AUTHOR=Fu Yulong , Wang Anqi , Zhou Jieqi , Feng Wei , Shi Minhua , Xu Xiao , Zhao Hongqing , Cai Liming , Feng Jian , Lv Xuedong , Zhang Xiaodong , Xu Wenjing , Zhang Zhengrong , Ma Guoer , Wang Jian , Zhou Tong , Zhao Dahai , Fang Haohui , Liu Zeyi , Huang Jian-an 

TITLE=Corrigendum: Advanced NSCLC patients with EGFR T790M harbouring TP53 R273C or KRAS G12V cannot benefit from osimertinib based on a clinical multicentre study by tissue and liquid biopsy

JOURNAL=Frontiers in Oncology

VOLUME=13

YEAR=2023

URL=https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1236311

DOI=10.3389/fonc.2023.1236311

ISSN=2234-943X